MannKind Corporation (NASDAQ:MNKD) Net Profit Margin stood at 71.90%%. The company’s Return on Assets were 115.30%%. At the close of the day, the stock reported a Market Cap of $150.00M in the Biotechnology Industry.
The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Minimum.
Recently, MannKind Corporation (NASDAQ:MNKD) reported financial results for the first quarter ended March 31, 2017.
The company traded a total volume of 31,894,669, and the stock saw a change of 42.86% in the previous trading session. The company reported a 52-Week High of $-32.77% and a52-Week Low of $290.24%. The monthly Volatility of MannKind Corporation stood at 16.10%.
MannKind Corporation announced EPS of $1.26. This represents a growth of 130.10% in EPS this year compared to what was reported last financial year and represents an overall growth of 17.20% over the past five year. The company is now projecting an EPS growth of 26.80%% in the next five years.
MannKind Corporation?s ownership was spread out with Insider Ownership amounting to 0.10% while Institutional Ownership amounted to 19.40%. Total insider transactions was 16.94% and total Institutional Transactions was -0.47%.
Return on Assets reported was 115.30%. Return on Equity for the financial year was -43.20% while Return on Investments was -396.80%. Current and quick ratio amounted to 0.80 and 0.80 respectively.
The company announced a gross margin of 84.30% and an operating margin of 79.70%. The company has 93.75M shares outstanding at a price of $1.60 per share.
EPS growth reported for this year was 130.10%. For the past five years, the company has reported EPS growth of 17.20% with EPS growth for the next year projected to be -5.70% while EPS growth for the next five years is projected to be 26.80%.